The PE Ratio as of November 2024 (TTM) for ViewRay, Inc. (VRAY) is -0.10

According to ViewRay, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -98.23% compared to the average of -5.66 of the last 4 quarters.

ViewRay, Inc. (VRAY) Historical PE Ratio (quarterly & annually)

How has VRAY PE Ratio performed in the past?

The mean historical PE Ratio of ViewRay, Inc. over the last ten years is -4.36. The current -0.10 PE Ratio has changed 129.20% with respect to the historical average. Over the past ten years (40 quarters), VRAY's PE Ratio was at its highest in in the November 2014 quarter at 0. The PE Ratio was at its lowest in in the November 2013 quarter at -11014.25.

ViewRay, Inc. (VRAY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ViewRay, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ViewRay, Inc. (VRAY) Average PE Ratio

How has VRAY PE Ratio performed in the past?

The current PE Ratio of ViewRay, Inc. (VRAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ViewRay, Inc. (VRAY) PE Ratio vs. Peers

How is VRAY’s PE Ratio compared to its peers?

ViewRay, Inc.’s PE Ratio is greater than Alphatec Holdings, Inc. (-8.12), less than Acutus Medical, Inc. (-0.05), greater than AxoGen, Inc. (-40.92), greater than Delcath Systems, Inc. (-8.22), greater than NeuroPace, Inc. (-10.17), greater than CVRx, Inc. (-5.79), greater than Orthofix Medical Inc. (-6.11), greater than Artivion, Inc. (-1396.61), greater than Heska Corporation (-67.36), greater than Anika Therapeutics, Inc. (-2.57), greater than Sight Sciences, Inc. (-4.01), less than Avanos Medical, Inc. (54.50), greater than Bone Biologics Corporation (-0.30), greater than Heart Test Laboratories, Inc. (-0.28), greater than Tivic Health Systems, Inc. (-0.24), greater than Vivos Therapeutics, Inc. (-1.68), less than Talis Biomedical Corporation (-0.06), greater than Inogen, Inc. (-4.23), greater than Establishment Labs Holdings Inc. (-17.03),

Build a custom stock screener for ViewRay, Inc. (VRAY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ViewRay, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ViewRay, Inc. (VRAY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ViewRay, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.